Bladex Can Benefit From The Middle East Conflict Incrementing Trade Financing (NYSE:BLX)

BLX stays a Buy: undervalued with 13% loan growth and 24% fee income offsetting NIM pressure; ROE guided 14–15% with low impaired credits.

You are being redirected to the original discussion. Please continue if you want to read the full post.

You will be redirected in 3 seconds.